Announcements Trials
Browse Landscape

Phase

Phase 1/2 11Phase 2 9Phase NA 3Phase EARLY_PHASE1 2

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Gynecologic 1

Conditions

Peripheral Nervous System Diseases 1Pain 1Ovarian Neoplasms 1Cancer Cachexia 1Breastcancer 1Breast Neoplasms 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 259Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 146Surgical Procedures, Operative 135Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 79Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Omacor × Clear all
NCT01821833 2022-10-05

Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel

New Mexico Cancer Research Alliance

Phase NA Completed
60 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pain, Peripheral Nervous System Diseases

NCT02996240 2021-03-17

Breast, Omega 3 Free Fatty Acid, Ph 0

The University of Texas Health Science Center at San Antonio

Phase NA Completed
21 enrolled
Breast

Breastcancer

NCT00815685 2017-03-23

A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
36 enrolled 7 charts

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡